[logo] HealthTree Foundation
more_vert
close
person Sign In / Create Account

Dr. Aaron Rapoport, MD on the progress and potential for T-cell and vaccine myeloma therapies

Dr. Aaron Rapoport, MD on the progress and potential for T-cell and vaccine myeloma therapies image

Dr. Aaron Rapoport, MD on the progress and potential for T-cell and vaccine myeloma therapies

Podcast
event Mar 31, 2014 / 11:00AM MDT
link icon facebook logo X logo linkedin logo reddit logo email icon

Event Description

 

Learn about all myeloma happenings on the new Myeloma Crowd site: the first comprehensive site for myeloma patients and caregivers. Dr. Aaron Rapoport, MD University of Maryland Greenbaum Cancer Center Interview date: March 28, 2014  Dr. Aaron Rapoport shares the progress being made on T cell and vaccine immunotherapy. T cell therapy is a way to use a patient's own immune system cells to target and eliminate myeloma cells, either by waking up and empowering T cells through engineering (called CAR T cells)  or using a vaccine to stimulate the T cells to do their job. He shares how transplant is being used to eliminate the myeloma cells and T cells are being used to build back up the immune system to prevent future infections, like pneumonia. Although T cells are being used traditionally in combination with transplant, he shares how this is being used even without transplant in a newly opened study at the University of Maryland and City of Hope clinics. He shares how he and others are carefully moving forward with T cell approaches in order to create targets that just hit the myeloma cells while sparing healthy cells. He describes how you can join a T cell study by knowing your HLA tissue typing, an easy test to obtain that is performed by major labs. This test tissue typing is typically used if a patient is trying to find a donor transplant match.     The live mPatient Myeloma Radio podcast with Dr. Aaron Rapoport 

Schedule & Agenda

Event panelist Dr. Aaron Rapoport & Jenny Ahlstrom
11:00 AM
Discussion
Dr. Aaron Rapoport & Jenny Ahlstrom

Speakers & Moderators

The panelist Jennifer Ahlstrom
Jennifer Ahlstrom

Myeloma survivor, patient advocate, wife, mom of 6. Believer that patients can help accelerate a cure by weighing in and participating in clinical research. Founder of the HealthTree Foundation.

Read Bio

Have Any Questions?

Thank you for your interest in the event. If you have any questions, we would love to help!

Feel free to give us a call or send us a message below.

support

Get In Touch With Us

phone

1-800-709-1113

email

Support@healthtree.org

Thanks to our sponsors:
Johnson and Johnson logo
Sanofi logo
Pfizer logo
GSK logo
Regeneron logo
All HealthTree resources available anywhere, anytime
Download our App
Download iOS App Download Android App
iphone app mockup
newsletter icon

Get the Latest Blood Cancer Updates, Delivered to You.

By subscribing to the HealthTree newsletter, you'll receive the latest research, treatment updates, and expert insights to help you navigate your health.